Content Library | Clinical Trial Supply Forum

The Clinical Trial Supply Forum 2024 Agenda

The Clinical Trial Supply Forum (14-16 May, 2024 in Brussels, Belgium) is a platform where Clinical Trial Supply professionals on all seniority levels gather to exchange exclusive insights, establish valuable connections and collaboratively tackle industry challenges.Join you ...

Event Information

Clinical Trial Supply Forum Sample Attendee List

Interested in seeing who you can meet at the Clinical Trial Supply Forum 2024? Download our sample attendee list to see which of your industry peers are going to be at CTS 2024. 

Convince Your Boss Letter - Join us at the Clinical Trial Forum!

Present your boss with this customizable letter detailing the reasons why you should attend Clinical Trial Supply Forum 2024 from 14 – 16 May, 2024 in Brussels, Belgium. Just download the letter template below, adjust as necessary (or edit as needed) and submit! We hope to welcome you there!

2024 Clinical Trial Supply Insights

Infographic: A Step-by-Step Guide to Building a Clinical Trial Supply Strategy

In an era where clinical trials are becoming increasingly complex and global, developing a robust supply strategy is more critical than ever. This strategic framework is designed to help you navigate the complex landscape of clinical trial supply, offering a step-by-step approach to crafting a resilient and adaptable strategy.

Clinical Trial Supply Forum 2024 Trends Report

The clinical trial supply industry is going through a period of rapid change, propelled by the aftermath of the pandemic and the rapid evolution of technology. Additionally, world-changing geopolitical events continue to impact supply chains across all sectors. Ahead of the 2024 Clinical Trial Supply Forum, Pharma IQ interviewed Advisory...

Post-Show Review: Top 10 Takeaways from the Clinical Trial Supply Forum: Infographic

Discover the key highlights and learnings from the 2023 Clinical Trial Supply Forum in a concise, informative infographic format and understand what's shaping the future of the clinical trial supply industry. 

How Leveraging Patient Insurance in SOC can Create Enrollment Barriers for your Trail and Strategies to Overcome Them

In the realm of clinical trials, patient recruitment poses a significant challenge, with merely 2%-5% of U.S. patients currently engaged in these crucial research endeavors. Patients represent the cornerstone of any clinical trial, without whom progress in developing novel therapies and advancing care innovation would stall. Consequently, ensuring patient participation...

Leading Industry Resources

How Hybrid Container Solutions Benefit Pharma Supply Chains

The pharmaceutical sector loses billions of dollars annually due to logistical failures including temperature excursions and a lack of end-to-end visibility. The rapid shipment of vaccines worldwide to tackle Covid-19 highlighted the need for transport containers that adequately protect the medicines they are delivering. Since the pandemic began in 2020,...

Direct-to-Patient Case Study - Alexandra Tsioni, Associate Director, Clinical Supply Chain Global Lead, Israel

Alexandra Tsioni, Associate Director, Clinical Supply Chain Global Lead, Israel, brilliantly presented a 'Direct-to-Patient Case Study' at the Clinical Trial Supply Forum 2022. Download your copy to learn more about: The impact of COVID-19 on clinical trials Direct-to-patient vs traditional approaches The impact on clinical supplies Direct-to-patient case study considerations,...

Building reverse logistics and product reconciliations into your supply strategy to optimise end to end distribution management - Kamal Amin, Head of Supply Management, Galderma

Building reverse logistics and product reconciliations into your supply strategy to optimise end to end distribution management was delivered at the Clinical Trial Supply Forum 2022 by Kamal Amin, Head of Supply Management, Galderma.Download your copy to discover:The role of clinical supplies teams within the reverse logistics and reconciliations management...